
Regulatory Assessment — Learning about Expanded Access and Potential of the Levonorgestrel Intrauterine System (LEAP LNG-IUS)
With funding from the Bill & Melinda Gates Foundation, FHI 360 and partners Population Services
International (PSI) and WCG Cares are implementing the Learning about Expanded Access and Potential of
the LNG-IUS (LEAP LNG-IUS) Initiative. The project is intended to help determine if and how expanded
access to the levonorgestrel intrauterine system (LNG-IUS) — a long-acting contraceptive — could
increase contraceptive use and continuation rates in sub-Saharan Africa. Activities include research
among women and providers in Nigeria and Zambia as well as demand forecasting in Kenya, Nigeria and
Zambia. The findings from the project will help stakeholders better understand the potential demand for
the LNG-IUS, experiences among users and providers, and continuation rates and cost-effectiveness of
the LNG-IUS compared with other long-acting reversible contraceptive (LARC) methods.
November 2018
Click for full info +Regulatory Assessment — Learning about Expanded Access and Potential of the Levonorgestrel Intrauterine System (LEAP LNG-IUS)
November 2018 |
- Regulatory Assessment
- Levonorgestrel Intrauterine System
- LEAP LNG-IUS
- United States
Full Info:
Resource Type:
Citation:
WCG Cares, FHI360, Population Services International
Product type(s):
- Contraceptives
Topic(s):
- Development
- Regulatory
Region(s)
- United States
URL of resource: